Submit Deal

HENLIUS

Summary

Henlius is a global biopharmaceutical company offering biologic medicines for patients suffering from oncology, autoimmune and ophthalmic diseases.

Deals Overview

Total Dealss1

Valued Deals1

Total Value£ 543 M

Avg. Deal Size£ 543 M

Market Context

Senior Management

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy